For the first time, researchers have landed on a potential diagnostic method to identify at least a subset of patients with chronic fatigue syndrome – testing for antibodies linked to latent Epstein-Barr virus reactivation.
For the first time, researchers have landed on a potential diagnostic method to identify at least a subset of patients with chronic fatigue syndrome – testing for antibodies linked to latent Epstein-Barr virus reactivation.